Signals elicited at the intestinal epithelium upon chitosan feeding contribute to immunomodulatory activity and biocompatibility of the polysaccharide

Vaccine

Volumn 28, Issue 35, 2010, Pages 5718-5724

  Canali, M Magdalena ^a   Porporatto, Carina ^a   Aoki, M Pilar ^a   Bianco, Ismael D ^b   Correa, Silvia G ^a  

^a UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

^b Universidad Nacional de La Rioja   (Argentina)

Author keywords

Arginase; Chitosan; Cytokines; Epithelium; Inflammation

Indexed keywords

ARGINASE; CHEMOKINE; CHITOSAN; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 6; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ARTICLE; BIOCOMPATIBILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FEMALE; IMMUNOMODULATION; INTESTINE EPITHELIUM; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; RAT; SINGLE DRUG DOSE; ANIMAL; CELL CULTURE; CYTOLOGY; EPITHELIUM CELL; IMMUNOLOGY; INTESTINE MUCOSA; METABOLISM; MUCOSAL IMMUNITY; ORAL DRUG ADMINISTRATION; WISTAR RAT;

ADMINISTRATION, ORAL; ANIMALS; ARGINASE; CELLS, CULTURED; CHEMOKINES; CHITOSAN; EPITHELIAL CELLS; FEMALE; IMMUNITY, MUCOSAL; IMMUNOMODULATION; INTERLEUKIN-10; INTERLEUKIN-6; INTESTINAL MUCOSA; RATS; RATS, WISTAR; TRANSFORMING GROWTH FACTOR BETA;

EID: 77955090676     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.06.027     Document Type: Article

References (49)

1. Baudner B.C., Giuliani M.M., Verhoef J.C., Rappuoli R., Junginger H.E., Giudice G.D. The concomitant use of the LTK63 mucosal adjuvant and of chitosan-based delivery system enhances the immunogenicity and efficacy of intranasally administered vaccines. Vaccine 2003, 21(25-26):3837-3844.
2. Illum L. Chitosan and its use as a pharmaceutical excipient. Pharm Res 1998, 15(99):1326-1331.
3. Lim B.O., Yamada K., Nonaka M., KuramotoY, Hung P., Sugano M. Dietary fibers modulate indices of intestinal immune function in rats. J Nutr 1997, 127(5):663-667.
4. Mills K.H., Cosgrove C., McNeela E.A., Sexton A., Giemza R., Jabbal-Gill I., et al. Protective levels of diphtheria-neutralizing antibody induced in healthy volunteers by unilateral priming-boosting intranasal immunization associated with restricted ipsilateral mucosal secretory immunoglobulin a. Infect Immun 2003, 71(2):726-732.
5. McNeela E.A., Jabbal-Gill I., Illum L., Pizza M., Rappuoli R., Podda A., et al. Intranasal immunization with genetically detoxified diphtheria toxin induces T cell responses in humans: enhancement of Th2 responses and toxin-neutralizing antibodies by formulation with chitosan. Vaccine 2004, 22(8):909-914.
6. Read R.C., Naylor S.C., Potter C.W., Bond J., Jabbal-Gill I., Fisher A., et al. Effective nasal influenza vaccine delivery using chitosan. Vaccine 2005, 23(35):4367-4374.
7. van der Lubben I., Kersten G., Fretz M.M., Beuvery C., Coos V.J., Junginger H.E. Chitosan microparticles for mucosal vaccination against diphtheria: oral and nasal efficacy studies in mice. Vaccine 2003, 21(13-14):1400-1408.
8. Kang M.L., Kang S.G., Jiang H.L., Shin S.W., Lee D.Y., Ahn J.M., et al. In vivo induction of mucosal immune responses by intranasal administration of chitosan microspheres containing Bordetella bronchiseptica DNT. Eur J Pharm Biopharm 2006, 63(2):215-220.
9. Porporatto C., Bianco I.D., Cabanillas A.M., Correa S.G. Early events associated to the oral co-administration of type II collagen and chitosan: induction of anti-inflammatory cytokines. Int Immunol 2004, 16(3):433-441.
10. Porporatto C., Bianco I.D., Correa S.G. Local and systemic activity of the polysaccharide chitosan at lymphoid tissues after oral administration. J Leukoc Biol 2005, 78(1):62-69.
11. Porporatto C., Canali M.M., Bianco I.D., Correa S.G. Ability of the polysaccharide chitosan to inhibit proliferation of CD4+ lymphocytes from mucosal inductive sites, in vitro and in vivo. Cell Prolif 2009, 42(6):780-787.
12. Porporatto C., Canali M.M., Bianco I.D., Correa S.G. The biocompatible polysaccharide chitosan enhances the oral tolerance to type II collagen. Clin Exp Immunol 2009, 155(1):79-87.
13. Muller C.A., Autenrieth I.B., Peschel A. Innate defenses of the intestinal epithelial barrier. Cell Mol Life Sci 2005, 62(12):1297-1307.
14. Neutra M.R., Mantis N.J., Kraehenbuhl J.P. Collaboration of epithelial cells with organized mucosal lymphoid tissues. Nat Immunol 2001, 1(11):1004-1009.
15. Smith P.D., Smythies L.E., Mosteller-Barnum M., Sibley D.A., Russell M.W., Merger M., et al. Intestinal macrophages lack CD14 and CD89 and consequently are down-regulated for LPS- and IgA-mediated activities. J Immunol 2001, 167(5):2651-2656.
16. Rimoldi M., Chieppa M., Salucci V., Avogadri F., Sonzogni A., Sampietro G.M., et al. Intestinal immune homeostasis is regulated by the crosstalk between epithelial cells and dendritic cells. Nat Immunol 2005, 6(5):507-514.
17. Gütgemann I., Fahrer A.M., Altman J.D., Davis M.M., Chien YH Induction of rapid T cell activation and tolerance by systemic presentation of an orally administered antigen. Immunity 1998, 8(6):667-673.
18. Benson J.M., Campbell K.A., Guan Z., Gienapp I.E., Stuckman S.S., Forsthuber T., et al. T-cell activation and receptor downmodulation precede deletion induced by mucosally administered antigen. J Clin Invest 2000, 106(8):1031-1038.
19. Kearsey J.A., Stadnyk A.W. Isolation and characterization of highly purified rat intestinal intraepithelial lymphocytes. J Immunol Methods 1996, 194(1):35-48.
20. Chou T.C., Fu E., Shen E.C. Chitosan inhibits prostaglandin E2 formation and cyclooxygenase-2 induction in lipopolysaccharide-treated RAW 264.7 macrophages. Biochem Biophys Res Commun 2003, 308(2):403-407.
21. Porporatto C., Bianco I.D., Riera C.M., Correa S.G. Chitosan induces different l-arginine metabolic pathways in resting and inflammatory macrophages. Biochem Biophys Res Commun 2003, 304(2):266-272.
22. Jobin C., Hellerbrand C., Licato L.L., Brenner D.A., Sartor R.B. Mediation by NF-kappa B of cytokine induced expression of intercellular adhesion molecule 1 (ICAM-1) in an intestinal epithelial cell line, a process blocked by proteasome inhibitors. Gut 1998, 42(6):779-787.
23. van Niel G., Heyman M. The epithelial cell cytoskeleton and intracellular trafficking II. Intestinal epithelial cell exosomes: perspectives on their structure and function. Am J Physiol Gastrointest Liver Physiol 2002, 283(2):G251-G255.
24. Ponda P.P., Mayer L. Mucosal epithelium in health and disease. Curr Mol Med 2005, 5(6):549-556.
25. Iwasaki A., Kelsall B.L. Localization of distinct Peyer's patch dendritic cell subsets and their recruitment by chemokines macrophage inflammatory protein (MIP)-3alpha. MIP-3beta, and secondary lymphoid organ chemokine. J Exp Med 2000, 191(8):1381-1394.
26. Kobayashi H., Miura S., Nagata H., Tsuzuki Y., Hokari R., Ogino T., et al. In situ demonstration of dendritic cell migration from rat intestine to mesenteric lymph nodes: relationships to maturation and role of chemokines. J Leukoc Biol 2004, 75(3):434-442.
27. Berin M.C., Dwinell M.B., Eckmann L., Kagnoff M.F. Production of MDC/CCL22 by human intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol 2001, 280(6):G1217-G1226.
28. Dodane V., Amin K.M., Merwin J.R. Effect of chitosan on epithelial permeability and structure. Int J Pharm 1999, 182(1):21-32.
29. Schipper N.G., Varum K.M., Artursson P. Chitosans as absorption enhancers for poorly absorbable drugs. 1: Influence of molecular weight and degree of acetylation on drug transport across human intestinal epithelial (Caco-2) cells. Pharm Res 1996, 13(11):1686-1692.
30. Parkos C.A., Colgan S.P., Diamond M.S., Nusrat A., Liang T.W., Springer T.A., et al. Expression and polarization of intercellular adhesion molecule-1 on human intestinal epithelia: consequences for CD11b/CD18-mediated interactions with neutrophils. Mol Med 1996, 2(4):489-505.
31. Hershberg R.M., Framson P.E., Cho D.H., Lee L.Y., Kovats S., Beitz J., et al. Intestinal epithelial cells use two distinct pathways for HLA class II antigen processing. J Clin Invest 1997, 100(1):204-215.
32. Iwasaki A., Kelsall B.L. Mucosal immunity and inflammation I. Mucosal dendritic cells: their specialized role in initiating T cell responses. Am J Physiol 1999, 276(5 (Pt 1)):G1074-G1078.
33. Hahm K.B., Im Y.H., Parks T.W., Park S.H., Markowitz S., Jung H.Y., et al. Loss of transforming growth factor beta signalling in the intestine contributes to tissue injury in inflammatory bowel disease. Gut 2001, 498(2):190-198.
34. Sierro F., Dubois B., Coste A., Kaiserlian D., Kraehenbuhl J.P., Sirard J.C. Flagellin stimulation of intestinal epithelial cells triggers CCL20-mediated migration of dendritic cells. Proc Natl Acad Sci USA 2001, 98(24):13722-13727.
35. Karpus W.J., Kennedy K.J., Kunkel S.L., Lukacs N.W. Monocyte chemotactic protein 1 regulates oral tolerance induction by inhibition of T helper cell 1-related cytokines. J Exp Med 1998, 187(5):733-741.
36. DePaolo R.W., Rollins B.J., Kuziel W., Karpus W.J. CC chemokine ligand 2 and its receptor regulate mucosal production of IL-12 and TGF-beta in high dose oral tolerance. J. Immunol 2003, 171(7):3560-3567.
37. Iliev I.D., Matteoli G., Rescigno M. The yin and yang of intestinal epithelial cells in controlling dendritic cell function. J Exp Med 2007, 204(10):2253-2257.
38. Jarry A., Bossard C., Bou-Hanna C., Masson D., Espaze E., Denis M.G., et al. Mucosal IL-10 and TGF-β play crucial roles in preventing LPS-driven. IFN-γ-mediated epithelial damage in human colon explants. J Clin Invest 2008, 118(3):1132-1142.
39. Zaph C., Troy A.E., Taylor B.C., Berman-Booty L.D., Guild K.J., Du Y., et al. Epithelial-cell-intrinsic IKK-beta expression regulates intestinal immune homeostasis. Nature 2007, 446(7135):552-556.
40. Iliev I.D., Mileti E., Matteoli G., Chieppa M., Rescigno M. Intestinal epithelial cells promote colitis-protective regulatory T-cell differentiation through dendritic cell conditioning. Mucosal Immunol 2009, 2(4):340-350.
41. Autschbach F., Braunstein J., Helmke B., Zuna I., Schürmann G., Niemir Z.I., et al. In situ expression of interleukin-10 in noninflamed human gut and in inflammatory bowel disease. Am J Pathol 1998, 153(1):121-210.
42. Gookin J.L., Duckett L.L., Armstrong M.U., Stauffer S.H., Finnegan C.P., Murtaugh M.P., et al. Nitric oxide synthase stimulates prostaglandin synthesis and barrier function in C. parvum-infected porcine ileum. Am J Physiol Gastrointest Liver Physiol 2004, 287(3):G571-G581.
43. Cetin S., Leaphart C.L., Li J., Ischenko I., Hayman M., Upperman J., et al. Nitric oxide inhibits enterocyte migration through activation of RhoA-GTPase in a SHP-2-dependent manner. Am J Physiol Gastrointest Liver Physiol 2007, 292(5):G1347-G1358.
44. Stempelj M., Kedinger M., Augenlicht L., Klampfer L. Essential role of the JAK/STAT1 signaling pathway in the expression of inducible nitric-oxide synthase in intestinal epithelial cells and its regulation by butyrate. J Biol Chem 2007, 282(13):9797-9804.
45. Rhoads J.M., Chen W., Gookin J., Wu G.Y., Fu Q., Blikslager A.T., et al. Arginine stimulates intestinal cell migration through a focal adhesion kinase dependent mechanism. Gut 2004, 53(4):514-522.
46. Gobert A.P., Cheng Y., Akhtar M., Mersey B.D., Blumberg D.R., Cross R.K., et al. Protective role of arginase in a mouse model of colitis. J Immunol 2004, 173(3):2109-2117.
47. Wu G., Knabe D.A., Flynn N.E., Yan W., Flynn S.P. Am J Physiol 1996, 271(5 (Pt 1)):G913-G919.
48. Han X., Fink M.P., Yang R., Delude R.L. Increased iNOS activity is essential for intestinal epithelial tight junction dysfunction in endotoxemic mice. Shock 2004, 21(3):261-270.
49. Gómez-García L., Rivera-Montoya I., Rodríguez-Sosa M., Terrazas L.I. Carbohydrate components of Taenia crassiceps metacestodes display Th2-adjuvant and anti-inflammatory properties when co-injected with bystander antigen. Parasitol Res 2006, 99(4):440-448.